Exchange: NASDAQ·Updated 11:29 AM EDT
GELS logo

GELS Gelteq Ltd.

$0.5919
$0.0181
(2.97%)
Today
Mkt Cap$6.53M
Vol244,390.00

About GELS

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
45

Neutral Sentiment

How do you feel about GELS?

Aburose
$GELS Everyone knows this market is ailing, especially after Trump took office, but there are opportunities like this company, which is a better investment. Next week we might see the stock trading above $40.
1
5
Laminar_Flow
$GELS This thing has been looking like bart Simpson all ah but never dropped. Surprisingly strong and I'm holding a few thousand overnight. Sold half for decent gains.
1
4
EddieTuna
$GELS honestly what in the flying fuk is going on with the market now adays. Does anythinh just run without jack knifing
4
KevMomentum
$GELS consolidating nicely underneath pre-market resistance, so if this can break and base OVER that resistance, I'll play ball for the simple S/D flip setup. Range to $1.5/$2.00+ but as always, no break = no trade!
4
KevMomentum
$GELS after-hours gapper continuing it's perk up from earlier today with a solid 8PM close. Easily a top watch for tomorrow. Yet ANOTHER S/D flip setup here. All similar setups on my watchlist tonight. No break, no trade, range to $1.5/$2.00+ on the break higher
4
Trick2MoneyisHavingSum
$GELS no serious business - I won't name him but someone I know billionaire just hit me up and probably pushing this so STAY
1
Trick2MoneyisHavingSum
$GELS who tired of playing with these stubborn shorts - calling all whales will therealmfbearkillas pls stand up?
3
Holdenfomogainz
$GELS they are so trying to hold this down, but the buy pressure is gonna be to much. It has to burst today.
3
WilsonWorld
$GELS exited earlier $1.01 held there too long back in but it’s gotta get rsi and mac off the floor. Buy buy buy
3
premarketmaker
$GELS party left $GELS house for now - may be shifting to $BRNX - very low float miving higher - just watch for volume/680K float - no news
1
hopper954
$GELS Some odd buying going on Can’t tell if it’s covers or someone has info the rest of us do not
2
StockSenseiTrendTraders
One losing alert in five sessions. That was the entire week. Twenty seven of twenty eight worked, and it happened during a stretch where the market gave us very little to work with. $GELS was the best of them. $AKAN and $IMRN finished it strong this morning, with $NCRA and $BIAF in between. Every single one was covered on the Zoom before it moved.
2
Tradersway1
$GELS Has the best daily chart out of all the leaders this morning. Others will see this and launch it at open!
2
bigbulltoro
$GELS intentional trades where those .99 cent shorts you quiet like a mfr now always saying oo shorts activated I got shorts at every level punkass dip now squeeze his ass bulls
2
Modo6177
$GELS struggled all day for volume And, lo and behold, from 4-5 pm got like 200k volume plus…? Something is brewing….
1
LuckyIrish777
$GELS Is this all encouragement from a Discord group? I don’t see why it’s moving up. It has to be a pump and dump.
1
StockAuthority
$GELS 5% bounce already. Keep that bell icon on for my alerts, we make quick scalp gains and big long term swing gains 🔔
1
Swagger_Ape
🚀SUNE🚀 solar / energy play, with massive catalysts and 0 shares to short. This can see $5 and the high of June $9+ with news $GELS $SPWR $TRBG $AIB :))))))
1
INEEDMONEY87
$GELS some big shorts want to keep it below a dollar to keep cutting hundredths for cover...
1
Aburose
$GELS Here's the key summary Gelteq said it has made recent clinical and commercial progress in its gel-based delivery platform for pharma, animal health and consumer health. Key updates include completed human trial planning, with a trial expected to start next quarter and potentially support an FDA pathway; a veterinary antiparasitic trial already under way; and a preclinical diabetes study. The company also signed up to US$3.5 million in debt financing, completed veterinary palatability trials, manufactured a commercial product for a new East Asian customer, opened a Center of Excellence in Guangdong, and expanded its API pipeline.

Advertisement|Remove ads.